← Scroll for more →
Financial Statements — MAMK
Balance Sheet
(in millions USD)| Metric | Q2 2026 | Q4 2025 | Q2 2025 | Q4 2024 |
|---|---|---|---|---|
| Cash & Equivalents | 0.07 | 0.12 | 0.19 | 0.18 |
| Accounts Receivable | 14.58 | 9.88 | 6.01 | 6.19 |
| Inventory | 2.34 | 6.50 | 3.53 | 2.63 |
| Total Current Assets | 25.60 | 21.54 | 16.56 | 16.45 |
| Property, Plant & Equipment | 0.14 | 0.15 | 0.12 | 0.12 |
| Intangible Assets | 0.01 | 0.01 | 0.01 | 0.01 |
| Total Non-current Assets | 0.39 | 0.30 | 1.35 | 1.22 |
| Total Assets | 25.99 | 21.84 | 17.91 | 17.67 |
| Accounts Payable | 2.90 | 3.06 | 2.43 | -- |
| Short-term Debt | 3.42 | 1.95 | 2.17 | 2.79 |
| Total Current Liabilities | 11.74 | 6.89 | 7.73 | 7.35 |
| Long-term Debt | 2.15 | 2.30 | 1.84 | 2.06 |
| Total Non-current Liabilities | 0.75 | 2.34 | 1.85 | 2.06 |
| Total Liabilities | 12.49 | 9.23 | 9.57 | 9.41 |
| Retained Earnings | 6.32 | 5.73 | 5.97 | 5.81 |
| Total Stockholder Equity | 13.18 | 12.28 | 8.01 | 7.95 |
← Scroll for more columns →
Income Statement
(in millions USD)| Metric | Q2 2025 |
|---|---|
| Total Revenue | 12.40 |
| Cost of Revenue | 11.06 |
| Gross Profit | 1.34 |
| Research & Development | 0.46 |
| Selling, General & Admin | 0.42 |
| Total Operating Expenses | 1.17 |
| Operating Income | 0.18 |
| Pretax Income | 0.17 |
| Tax Provision | -0.00 |
| Net Income | 0.17 |
← Scroll for more columns →
Cash Flow Statement
(in thousands USD)| Metric | Q2 2025 |
|---|---|
| Operating Cash Flow | 846.93 |
| Capital Expenditures | 53.81 |
| Free Cash Flow* | 793.12 |
| Investing Cash Flow | (53.81) |
| Financing Cash Flow | (781.44) |
← Scroll for more columns →
* Derived from reported values